title: Association of genetic variation in adaptor protein APPL1/APPL2 loci with non-alcoholic fatty liver disease.
abstract: The importance of genetics and epigenetic changes in the pathogenesis of non alcoholic fatty liver disease (NAFLD) has been increasingly recognized. Adiponectin has a central role in regulating glucose and lipid metabolism and controlling inflammation in insulin-sensitive tissues and low adiponectin levels have been linked to NAFLD. APPL1 and APPL2 are adaptor proteins that interact with the intracellular region of adiponectin receptors and mediate adiponectin signaling and its effects on metabolism. The aim of our study was the evaluation of a potential association between variants at APPL1 and APPL2 loci and NAFLD occurrence. The impact on liver damage and hepatic steatosis severity has been also evaluated. To this aim allele frequency and genotype distribution of APPL1- rs3806622 and -rs4640525 and APPL2-rs 11112412 variants were evaluated in 223 subjects with clinical diagnosis of NAFLD and compared with 231 healthy subjects. The impact of APPL1 and APPL2 SNPs on liver damage and hepatic steatosis severity has been also evaluated. The minor-allele combination APPL1-C/APPL2-A was associated with an increased risk of NAFLD (OR = 2.50 95% CI 1.45-4.32; p<0.001) even after adjustment for age, sex, body mass index, insulin resistance (HOMA-IR), triglycerides and adiponectin levels. This allele combination carrier had higher plasma alanine aminotransferase levels (Diff = 15.08 [7.60-22.57] p = 0.001) and an increased frequency of severe steatosis compared to the reference allele combination (OR = 3.88; 95% CI 1.582-9.531; p<0.001). In conclusion, C-APPL1/A-APPL2 allele combination is associated with NAFLD occurrence, with a more severe hepatic steatosis grade and with a reduced adiponectin cytoprotective effect on liver.
authors: Department of Medical, Surgical, Neurological, Metabolic and Geriatric Sciences, Second University of Naples, Naples, Italy.
authors: Michelangela
authors: M
authors: Barbieri
authors: Antonietta
authors: A
authors: Esposito
authors: Edith
authors: E
authors: Angellotti
authors: Maria Rosaria
authors: MR
authors: Rizzo
authors: Raffaele
authors: R
authors: Marfella
authors: Giuseppe
authors: G
authors: Paolisso
mesh_terms: D048868:Adaptor Proteins, Signal Transducing / Q000235:genetics* / Q000378:metabolism; D052242:Adiponectin / Q000235:genetics / Q000378:metabolism; D000328:Adult; D000368:Aged; D000410:Alanine Transaminase / Q000097:blood; D000483:Alleles; D016022:Case-Control Studies; D005234:Fatty Liver / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D005260:Female; D005787:Gene Frequency; D056426:Genetic Loci; D005838:Genotype; D006801:Humans; D008297:Male; D008875:Middle Aged; D065626:Non-alcoholic Fatty Liver Disease; D020641:Polymorphism, Single Nucleotide; D054419:Receptors, Adiponectin / Q000235:genetics / Q000378:metabolism; D012720:Severity of Illness Index
chemical_list: C499918:ADIPOQ protein, human; C464801:APPL1 protein, human; C528555:APPL2 protein, human; D048868:Adaptor Proteins, Signal Transducing; D052242:Adiponectin; D054419:Receptors, Adiponectin; D000410:Alanine Transaminase
references: J Genet Genomics. 2013 Jan 20;40(1):15-22
references: 23357341
references: PLoS Genet. 2011 Mar;7(3):e1001324
references: 21423719
references: J Hepatol. 2005 Dec;43(6):1060-6
references: 16140415
references: Nature. 2003 Jun 12;423(6941):762-9
references: 12802337
references: Chin Med J (Engl). 2011 Nov;124(22):3618-21
references: 22340213
references: Ann Hum Genet. 2004 Mar;68(Pt 2):165-77
references: 15008795
references: Diabetes. 2011 Nov;60(11):3044-54
references: 21926268
references: Am J Physiol Endocrinol Metab. 2009 Jan;296(1):E22-36
references: 18854421
references: Diabet Med. 2007 Aug;24(8):817-22
references: 17490420
references: Hepatology. 2012 Jan;55(1):327-8
references: 21898508
references: Nat Med. 2002 Nov;8(11):1288-95
references: 12368907
references: Hepatology. 2005 Nov;42(5):1175-83
references: 16231364
references: Clin Liver Dis. 2004 Aug;8(3):575-94, ix
references: 15331065
references: Cell Metab. 2006 Jul;4(1):5-6
references: 16814726
references: Diabetes Care. 2000 Jan;23(1):57-63
references: 10857969
references: J Dig Dis. 2008 May;9(2):108-12
references: 18419645
references: Cell Metab. 2009 May;9(5):417-27
references: 19416712
references: BMC Med Genet. 2012 Mar 30;13:22
references: 22462604
references: Hepatology. 2006 Feb;43(2 Suppl 1):S99-S112
references: 16447287
references: Diabetes Obes Metab. 2010 May;12(5):365-83
references: 20415685
references: Clin Endocrinol (Oxf). 2006 Jun;64(6):679-83
references: 16712671
references: FASEB J. 2005 Aug;19(10):1266-71
references: 16051693
references: Dig Liver Dis. 2010 Apr;42(4):272-82
references: 20171943
references: Cytokine. 2008 Oct;44(1):201-6
references: 18789715
references: J Biol Chem. 2007 Nov 2;282(44):32280-7
references: 17848569
references: Curr Mol Med. 2009 Apr;9(3):299-314
references: 19355912
references: Nat Cell Biol. 2006 May;8(5):516-23
references: 16622416
references: World J Gastroenterol. 2012 Dec 7;18(45):6546-51
references: 23236228
references: J Biol Chem. 2009 Nov 13;284(46):31608-15
references: 19661063
references: J Gastroenterol. 2009;44(9):976-82
references: 19484180
references: Gastroenterology. 2012 Jun;142(7):1592-609
references: 22656328
references: Traffic. 2008 Feb;9(2):215-29
references: 18034774
references: Diabetes. 2007 May;56(5):1387-94
references: 17287464
references: Hepatology. 2005 Jul;42(1):44-52
references: 15895401
references: Diabetologia. 1985 Jul;28(7):412-9
references: 3899825
references: Br Med J (Clin Res Ed). 1986 Jan 4;292(6512):13-5
references: 3080046
references: Zhonghua Yi Xue Za Zhi. 2008 Feb 5;88(6):369-73
references: 18581887
references: Mol Cell Endocrinol. 2007 Jan 2;260-262:93-9
references: 17030088